Cargando…

Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography

BACKGROUND: Liver disease severity must be determined before treatment of chronic hepatitis C (CHC). We evaluated the diagnostic performance of the APRI and FIB-4 scores compared to transient elastography liver stiffness (TE-LS) in detecting significant fibrosis (F3) or cirrhosis (F4). METHODS: We r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadopoulos, Nikolaos, Vasileiadi, Sofia, Papavdi, Maria, Sveroni, Eirini, Antonakaki, Pinelopi, Dellaporta, Erminia, Koutli, Evangelia, Michalea, Stavroula, Manolakopoulos, Spilios, Koskinas, John, Deutsch, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686098/ https://www.ncbi.nlm.nih.gov/pubmed/31474797 http://dx.doi.org/10.20524/aog.2019.0406

Ejemplares similares

Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting
por: Koustenis, Kanellos Rafail, et al.
Publicado: (2020)

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues
por: Papadopoulos, Nikolaos, et al.
Publicado: (2018)

Substantial concordance between transient elastography and APRI and FIB-4 combination amongst hepatitis C inmates with non advanced liver fibrosis
por: Yela, E, et al.
Publicado: (2022)

Relationship of FIB-4 index with transient elastography in chronic hepatitis C patients having APRI ≥ 0.5 - ≤2 in a resource-limited setting in Pakistan
por: Ishtiaq, Annum, et al.
Publicado: (2020)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Accuracy of transient elastography-FibroScan(®), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
por: Ragazzo, Taisa Grotta, et al.
Publicado: (2017)

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein
por: Deutsch, Melanie, et al.
Publicado: (2018)

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level
por: Yen, Yi-Hao, et al.
Publicado: (2018)

Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients
por: Yunihastuti, Evy, et al.
Publicado: (2020)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

APRI and FIB-4 indices as diagnostic noninvasive scores for prediction of severe fibrosis in patients with biliary atresia
por: Nagi, Salma Abdel Megeed, et al.
Publicado: (2023)

A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis
por: Mercedes, Rebecca, et al.
Publicado: (2020)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community
por: Cheng, Pin-Nan, et al.
Publicado: (2018)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients
por: Zhang, Ze-Qun, et al.
Publicado: (2019)

Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B
por: Li, Qiang, et al.
Publicado: (2017)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts
por: Keimburg, Simone Anna, et al.
Publicado: (2022)

Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C
por: Mendes, L.C., et al.
Publicado: (2016)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2011)

Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China
por: Huang, Rui, et al.
Publicado: (2017)

APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection
por: Rungta, Sumit, et al.
Publicado: (2021)

FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study
por: Catanzaro, Roberto, et al.
Publicado: (2021)

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis
por: Kranidioti, Hariklia, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index
por: Margariti, Ekaterini, et al.
Publicado: (2012)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study
por: Deng, Han, et al.
Publicado: (2015)

Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
por: Fallatah, Hind I., et al.
Publicado: (2016)

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
por: Unsal, İlknur Ozturk, et al.
Publicado: (2022)

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores
por: Kang, Na-Ling, et al.
Publicado: (2022)

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
por: Kolhe, Kailash Marotrao, et al.
Publicado: (2019)

Identification and external validation of the optimal FIB‐4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings
por: Liu, Kecheng, et al.
Publicado: (2020)

Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population
por: Saleem, Nabil, et al.
Publicado: (2021)

The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2023)

Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection
por: Mendeni, M, et al.
Publicado: (2010)

A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India
por: Rungta, Sumit, et al.
Publicado: (2021)

AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran
por: Moosavy, Seyed Hamid, et al.
Publicado: (2023)

COVID-19 and liver injury: where do we stand?
por: Papadopoulos, Nikolaos, et al.
Publicado: (2020)

Transient Elastography (TE) is a Useful Tool for Assessing the Response of Liver Iron Chelation in Sickle Cell Disease Patients
por: Delicou, Sophia, et al.
Publicado: (2018)

Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study
por: Li, Qiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i31oa6hk0m8m774j4vc7f7ch0h